Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases

Cancer Research

Volumn 56, Issue 12, 1996, Pages 2707-2710

  Imai, Kazushi ^a   Ohuchi, Eiko ^a,b   Aoki, Takanori ^b   Nomura, Hidehiro ^a   Fujii, Yutaka ^c   Sato, Hiroshi ^a   Seiki, Motoharu ^a   Okada, Yasunori ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b FUJI CHEMICAL INDUSTRIES LTD   (Japan)

^c UNIVERSITY OF FUKUI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CARBOXY TERMINAL SEQUENCE; DELETION MUTANT; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC TRANSFECTION; NONHUMAN; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS;

ANIMALS; ANTIBODIES, MONOCLONAL; BASE SEQUENCE; BREAST NEOPLASMS; CHO CELLS; COLLAGENASES; CRICETINAE; ENZYME ACTIVATION; FURIN; GELATIN; GELATINASES; GENETIC VECTORS; HUMANS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; METALLOENDOPEPTIDASES; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; MUTAGENESIS, SITE-DIRECTED; PROTEINS; SUBTILISINS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSFECTION;

EID: 0030010940     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Nagase, H., and Okada, Y. Proteinases and matrix degradation. In: W. N. Kelley, E. D. Harris, Jr. S. Ruddy, and C. B Sledge (eds.), Textbook of Rheumatology. Philadelphia W. B. Saunders Company, in press, 1996
2. Steller-Stevenson, W. G., Aznavoorian, S , and Liotta, L. A Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol., 9: 541-573, 1993.
3. Nomura, H. Sato, H., Seiki, M., Mai, M., and Okada, Y Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res., 55: 3263-3256, 1995
4. Okada, Y., Morodomi, T. Enghild, J J , Suzuki, K , Yasui, A., Nakanishi, I., Salvesen, G., and Nagase, H Matrix metalloproteinase 2 from human synovial fibroblasts. Eur. J. Biochem , 194: 721-730, 1990.
5. Atkinson, S J., Ward, R V., Reynolds, J. J., and Murphy, G. Cell-mediated degradation of type IV collagen and gelatin films is dependent on the activation of matrix metalloproteinase. Biochem J., 288: 605-611, 1992.
6. Strongin, A Y , Marmer, B. L , Grant, G. A., and Goldberg, G. I. Plasma membrane-dependent activation of 72 kDa type IV collagenase is prevented by complex formation with TIMP-2 J. Biol. Chem., 268, 14033-14039, 1993
7. Sato, H , Takino, T., Okada, Y., Cao, J., Shinagawa, A , Yamamoto, E., and Seiki, M. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature (Lond.), 370, 61-65, 1994.
8. Tokuraku, M., Sato, H., Murakami, S., Okada, Y., Watanabe, Y , and Seiki, M. Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis Int. J. Cancer. 64: 355-359, 1995.
9. Strongin, A. Y , Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A , and Goldberg, G I Mechanism of cell surface activation of 72 kDa type IV collagenase. J Biol. Chem., 270 5331-5338, 1995.
10. Emmert-Buck, M., Emonard, H. P., Corcoran, M. L., Krutzsch, H. C , Foidart, J M., and Steller-Stevenson, W. G. Cell surface binding of TIMP-2 and proMMP-2/TIMP-2 complex. FEBS Lett., 364, 28-32, 1995.
11. Cao, J., Sato, H , Takino, T , and Seiki, M The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for progelatinase A activation J. Biol. Chem , 270: 801-805, 1995.
12. Kaufman, R. J., and Sharp, P A Amplification and expression of sequences cotransfected with a modular dihydrofolate reductase complementary DNA gene. J. Mol. Biol , 159: 601-621, 1982
13. Fujimoto, N., Mouri, N. Iwata, K., Ohuchi, E , Okada, Y , and Hayakawa, T. A one-step sandwich immunoassay for human matrix metalloproteinase 2 (72 kDa gelatinase/type IV collagenase) using monoclonal antibodies. Clin. Chim. Acta, 221: 91-103, 1993
14. Pei, D., and Weiss, S. J. Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature (Lond), 375: 244-247, 1995.
15. Bergmann, U , Tuuttila, A., Stetler-Stevenson, W G., and Tryggvason, K. Autolytic activation of recombinant human 72 kilodalton type IV collagenase. Biochemistry. 34 2819-2825, 1995.
16. r 72,000 type IV collagenase Cancer Res., 52: 5845-5848, 1992
17. Yu, M., Sato, H , Seiki, M , and Thompson, E W. Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells Cancer Res., 55 3272-3277, 1995.
18. Kodama, S., Iwata, K , Iwata, H., Yamashita, K., and Hayakawa, T Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases. An application for rheumatoid arthritis serum and plasma. J Immunol. Methods. 127: 103-108, 1990.
19. Itoh, Y., Binner, S , and Nagase, H. Steps involved in actuation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate Biochem. J., 308: 645-651, 1995